Gisslinger B - Search Results

1

A prognostic model to predict survival in 867 World Health Organization-defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and Treatment.

Passamonti F, Thiele J, Girodon F, Rumi E, Carobbio A, Gisslinger H, Kvasnicka HM, Ruggeri M, Randi ML, Gangat N, Vannucchi AM, Gianatti A, Gisslinger B, Müllauer L, Rodeghiero F, d'Amore ES, Bertozzi I, Hanson CA, Boveri E, Marino F, Maffioli M, Caramazza D, Antonioli E, Carrai V, Buxhofer-Ausch V, Pascutto C, Cazzola M, Barbui T, Tefferi A. Passamonti F, et al. Among authors: gisslinger h, gisslinger b. Blood. 2012 Aug 9;120(6):1197-201. doi: 10.1182/blood-2012-01-403279. Epub 2012 Jun 26. Blood. 2012. PMID: 22740446 Free article.

2

Autocrine cell suicide in a Burkitt lymphoma cell line (Daudi) induced by interferon alpha: involvement of tumor necrosis factor as ligand for the CD95 receptor.

Gisslinger H, Kurzrock R, Gisslinger B, Jiang S, Li S, Virgolini I, Woloszczuk W, Andreeff M, Talpaz M. Gisslinger H, et al. Among authors: gisslinger b. Blood. 2001 May 1;97(9):2791-7. doi: 10.1182/blood.v97.9.2791. Blood. 2001. PMID: 11313273 Free article.

3

Bone metabolism during interferon-alpha treatment of essential thrombocythemia.

Kusec R, Kusec V, Gisslinger B, Woloszczuk W, Gisslinger H. Kusec R, et al. Among authors: gisslinger h, gisslinger b. Wien Klin Wochenschr. 2004 Jan 31;116(1-2):37-41. doi: 10.1007/BF03040422. Wien Klin Wochenschr. 2004. PMID: 15030122

4

Elevated plasma osteoprotegerin levels are associated with venous thrombosis and bleeding in patients with polycythemia vera.

Kees M, Wiesbauer F, Gisslinger B, Wagner R, Shehata M, Gisslinger H. Kees M, et al. Among authors: gisslinger h, gisslinger b. Thromb Haemost. 2005 Jan;93(1):70-5. doi: 10.1160/TH04-06-0394. Thromb Haemost. 2005. PMID: 15630493

5

Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study.

Gisslinger H, Müllner M, Pabinger I, Heis-Vahidi-Fard N, Gisslinger B, Brichta A, Bachleitner-Hofmann T, Mannhalter C. Gisslinger H, et al. Among authors: gisslinger b. Haematologica. 2005 Mar;90(3):408-10. Haematologica. 2005. PMID: 15749677

6

Acquired resistance to interferon alpha therapy associated with homozygous MPL-W515L mutation and chromosome 20q deletion in primary myelofibrosis.

Buxhofer-Ausch V, Gisslinger H, Berg T, Gisslinger B, Kralovics R. Buxhofer-Ausch V, et al. Among authors: gisslinger h, gisslinger b. Eur J Haematol. 2009 Feb;82(2):161-3. doi: 10.1111/j.1600-0609.2008.01183.x. Epub 2008 Nov 10. Eur J Haematol. 2009. PMID: 19018861 No abstract available.

7

Asymmetric dimethylarginine levels in essential thrombocythemia--a retrospective analysis.

Massera D, Mittermayer F, Gisslinger B, Olcaydu D, Wolzt M, Gisslinger H. Massera D, et al. Among authors: gisslinger h, gisslinger b. Ann Hematol. 2011 Sep;90(9):1105-6. doi: 10.1007/s00277-010-1127-6. Epub 2010 Dec 3. Ann Hematol. 2011. PMID: 21127871 No abstract available.

8

Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification.

Thiele J, Kvasnicka HM, Müllauer L, Buxhofer-Ausch V, Gisslinger B, Gisslinger H. Thiele J, et al. Among authors: gisslinger h, gisslinger b. Blood. 2011 May 26;117(21):5710-8. doi: 10.1182/blood-2010-07-293761. Epub 2011 Mar 29. Blood. 2011. PMID: 21447832 Free article.

9

Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression.

Klampfl T, Harutyunyan A, Berg T, Gisslinger B, Schalling M, Bagienski K, Olcaydu D, Passamonti F, Rumi E, Pietra D, Jäger R, Pieri L, Guglielmelli P, Iacobucci I, Martinelli G, Cazzola M, Vannucchi AM, Gisslinger H, Kralovics R. Klampfl T, et al. Among authors: gisslinger h, gisslinger b. Blood. 2011 Jul 7;118(1):167-76. doi: 10.1182/blood-2011-01-331678. Epub 2011 Apr 29. Blood. 2011. PMID: 21531982 Free article.

10

Identification of oncostatin M as a JAK2 V617F-dependent amplifier of cytokine production and bone marrow remodeling in myeloproliferative neoplasms.

Hoermann G, Cerny-Reiterer S, Herrmann H, Blatt K, Bilban M, Gisslinger H, Gisslinger B, Müllauer L, Kralovics R, Mannhalter C, Valent P, Mayerhofer M. Hoermann G, et al. Among authors: gisslinger h, gisslinger b. FASEB J. 2012 Feb;26(2):894-906. doi: 10.1096/fj.11-193078. Epub 2011 Nov 3. FASEB J. 2012. PMID: 22051730

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

62 results

Search Page

Filters